The Anti-EGFR Cetuximab Biosimilar Monoclonal Antibody (HDBS0034) is a cutting-edge biopharmaceutical product designed to target the epidermal growth factor receptor (EGFR) in cancer cells. This monoclonal antibody, derived from Cetuximab, is highly specific and binds to the EGFR protein with high affinity, inhibiting its activation and downstream signaling pathways.EGFR is a key player in cell growth, proliferation, and survival, and its overexpression or mutations are commonly found in various types of cancer, making it an attractive target for cancer therapy. The Anti-EGFR Cetuximab Biosimilar Monoclonal Antibody offers a promising approach for treating EGFR-positive tumors by blocking its signaling, promoting apoptosis, and suppressing tumor growth.
This biosimilar monoclonal antibody has been extensively characterized and validated for use in preclinical and clinical research, including cell-based assays, ELISA, and immunohistochemistry. Its efficacy and safety profile make it a valuable tool for studying EGFR-targeted therapies and developing novel treatment strategies for cancer patients. Unlock the potential of precision medicine with the Anti-EGFR Cetuximab Biosimilar Monoclonal Antibody for your research needs.
Product Name:
Cetuximab (Anti-EGFR) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0034
Target:
EGFR
Host Species:
Chimeric
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
Fab C225,IMC-225
Description:
Anti-EGFR (Cetuximab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
